HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

TetroMycin B

HCID 178671290
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
180027-84-3
Standard SMILES
CC1=C[C@H]2[C@@H]([C@@H](C)CC[C@@H]2O)[C@]2(C)C(=O)C3=C(O)[C@@]4(C[C@@H](C)C(C)=C[C@]4(C)/C=C(\C)CC/C=C(\C)C12)OC3=O
InChIKey
GSWPHUYQJATONQ-SKYGGBABSA-N
Molecular formula
C34H46O5
Average molar mass
534.726 g/mol

Names & identifiers

Preferred name
TetroMycin B
English name
TetroMycin B
Molecular formula
C34H46O5
Molecular weight
534.72604

Names & synonyms

TetroMycin B18H-16a,19-Metheno-16aH-benzo[b]naphth[2,1-j]oxacyclotetradecin-18,20(1H)-dione, 2,3,4,4a,6a,9,10,12a,15,16,20a,20b-dodecahydro-4,21-trihydroxy-1,6,7,11,12a,14,15,20a-octamethyl-, (1S,4S,4aS,6aR,7E,11E,12aR,15R,16aS,20aS,20bR)- (9CI)

Database identifiers

CAS
180027-84-3

Properties

Physicochemical properties

Boiling point
680 · 680.0±55.0 °C(Predicted)
Density
1.17 · 1.17±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
form
A solid
pka
4.5 · 4.50±1.00(Predicted)

Chemistry & industry

Applications · 3 items

DescriptionTetromycin B is a cysteine protease inhibitor with Ki values of 0.62, 1.42, 32.5, and 1.59 μM for rhodesain, falcipain-2, cathepsin L, and cathepsin B, respectively. It inhibits the growth of T. brucei in vitro (IC50 = 30.87 μM). Tetromycin B is also cytotoxic to HEK293T kidney cells and J774.1 macrophages (IC50s = 71.77 and 20.2 μM, respectively).

UsesTetromycin B is an unusual tetronic acid, structurally related to kijanimicin, chlorothricin, saccharocarcin, tetrocarcin and versipelostatin. Tetromycin B has pronounced activity against antibiotic susceptible and resistant Gram positive bacteria including MRSA. Limited availability has restricted further investigation of this metabolite in the literature. Several members of this class have received considerable literature focus. Versipelostatin inhibits transcription from the promoter of GRP78, a gene that is activated as part of a stress signalling pathway under glucose deprivation resulting in unfolded protein response (UPR). The UPR-inhibitory action is seen only in conditions of glucose deprivation and causes selective and massive killing of the glucose-deprived cells. Tetrocarcin A appears to target the phosphatidylinositide-3'-kinase/Akt signalling pathway.

UsesTetromycin B is an unusual tetronic acid structured antibiotic showing efficacy against MRSA.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes